English
简体中文
Total: £ 56.28
Published Date: 2026-01-08 | Pages: 117 | Tables: 113 | Medical Care
The global AI Designed Antibodies market was valued at US$ 410 million in 2025 and is anticipated to reach US$ 1931 million by 2032, at a CAGR of 24.8% from 2026 to 2032.
AI-designed antibodies refer to antibody discovery and engineering workflows that use machine learning/deep learning models to computationally generate, screen, and optimize antibody sequences and structures. By integrating antigen structure/epitope cues, antibody repertoire data, and experimental measurements (affinity, specificity, stability, immunogenicity, and developability), AI enables a closed loop of candidate generation, in silico ranking, multi-objective optimization, and wet-lab validation—accelerating the creation of improved antibody molecules and supporting tasks such as de novo design, affinity maturation, humanization, and developability risk reduction.
The North American market for AI Designed Antibodies is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for AI Designed Antibodies is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for AI Designed Antibodies in Biological Experiments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of AI Designed Antibodies include Insilico Medicine, Generate:Biomedicines, Absci, Chai Discovery, Institute for Protein Design, Proteintech, AbCellera, LabGenius, Huashen, Tencent, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global AI Designed Antibodies market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI Designed Antibodies. The AI Designed Antibodies market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global AI Designed Antibodies market comprehensively. Regional market sizes by Type, by Application, by Design Input, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist AI Designed Antibodies manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Insilico Medicine
Generate:Biomedicines
Absci
Chai Discovery
Institute for Protein Design
Proteintech
AbCellera
LabGenius
Huashen
Tencent
Harbour BioMed
Dynegene Technologies
XtalPi
BioGeom
Segment by Type
Bispecific Antibodies
Multispecific Antibodies
Segment by Design Input
Structure-driven
Sequence-driven
Hybrid-driven
Segment by Application
Biological Experiments
Drug Development
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Design Input, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AI Designed Antibodies companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Designed Antibodies Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Bispecific Antibodies
1.2.3 Multispecific Antibodies
1.3 Market by Design Input
1.3.1 Global AI Designed Antibodies Market Size Growth Rate by Design Input: 2021 vs 2025 vs 2032
1.3.2 Structure-driven
1.3.3 Sequence-driven
1.3.4 Hybrid-driven
1.4 Market by Application
1.4.1 Global AI Designed Antibodies Market Growth by Application: 2021 vs 2025 vs 2032
1.4.2 Biological Experiments
1.4.3 Drug Development
1.4.4 Others
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global AI Designed Antibodies Market Perspective (2021–2032)
2.2 Global AI Designed Antibodies Growth Trends by Region
2.2.1 Global AI Designed Antibodies Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 AI Designed Antibodies Historic Market Size by Region (2021–2026)
2.2.3 AI Designed Antibodies Forecasted Market Size by Region (2027–2032)
2.3 AI Designed Antibodies Market Dynamics
2.3.1 AI Designed Antibodies Industry Trends
2.3.2 AI Designed Antibodies Market Drivers
2.3.3 AI Designed Antibodies Market Challenges
2.3.4 AI Designed Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Designed Antibodies Players by Revenue
3.1.1 Global Top AI Designed Antibodies Players by Revenue (2021–2026)
3.1.2 Global AI Designed Antibodies Revenue Market Share by Players (2021–2026)
3.2 Global Top AI Designed Antibodies Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by AI Designed Antibodies Revenue
3.4 Global AI Designed Antibodies Market Concentration Ratio
3.4.1 Global AI Designed Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Designed Antibodies Revenue in 2025
3.5 Global Key Players of AI Designed Antibodies Head Offices and Areas Served
3.6 Global Key Players of AI Designed Antibodies, Products and Applications
3.7 Global Key Players of AI Designed Antibodies, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 AI Designed Antibodies Breakdown Data by Type
4.1 Global AI Designed Antibodies Historic Market Size by Type (2021–2026)
4.2 Global AI Designed Antibodies Forecasted Market Size by Type (2027–2032)
5 AI Designed Antibodies Breakdown Data by Application
5.1 Global AI Designed Antibodies Historic Market Size by Application (2021–2026)
5.2 Global AI Designed Antibodies Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America AI Designed Antibodies Market Size (2021–2032)
6.2 North America AI Designed Antibodies Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America AI Designed Antibodies Market Size by Country (2021–2026)
6.4 North America AI Designed Antibodies Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Designed Antibodies Market Size (2021–2032)
7.2 Europe AI Designed Antibodies Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe AI Designed Antibodies Market Size by Country (2021–2026)
7.4 Europe AI Designed Antibodies Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AI Designed Antibodies Market Size (2021–2032)
8.2 Asia-Pacific AI Designed Antibodies Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific AI Designed Antibodies Market Size by Region (2021–2026)
8.4 Asia-Pacific AI Designed Antibodies Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AI Designed Antibodies Market Size (2021–2032)
9.2 Latin America AI Designed Antibodies Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America AI Designed Antibodies Market Size by Country (2021–2026)
9.4 Latin America AI Designed Antibodies Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Designed Antibodies Market Size (2021–2032)
10.2 Middle East & Africa AI Designed Antibodies Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa AI Designed Antibodies Market Size by Country (2021–2026)
10.4 Middle East & Africa AI Designed Antibodies Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Details
11.1.2 Insilico Medicine Business Overview
11.1.3 Insilico Medicine AI Designed Antibodies Introduction
11.1.4 Insilico Medicine Revenue in AI Designed Antibodies Business (2021–2026)
11.1.5 Insilico Medicine Recent Development
11.2 Generate:Biomedicines
11.2.1 Generate:Biomedicines Company Details
11.2.2 Generate:Biomedicines Business Overview
11.2.3 Generate:Biomedicines AI Designed Antibodies Introduction
11.2.4 Generate:Biomedicines Revenue in AI Designed Antibodies Business (2021–2026)
11.2.5 Generate:Biomedicines Recent Development
11.3 Absci
11.3.1 Absci Company Details
11.3.2 Absci Business Overview
11.3.3 Absci AI Designed Antibodies Introduction
11.3.4 Absci Revenue in AI Designed Antibodies Business (2021–2026)
11.3.5 Absci Recent Development
11.4 Chai Discovery
11.4.1 Chai Discovery Company Details
11.4.2 Chai Discovery Business Overview
11.4.3 Chai Discovery AI Designed Antibodies Introduction
11.4.4 Chai Discovery Revenue in AI Designed Antibodies Business (2021–2026)
11.4.5 Chai Discovery Recent Development
11.5 Institute for Protein Design
11.5.1 Institute for Protein Design Company Details
11.5.2 Institute for Protein Design Business Overview
11.5.3 Institute for Protein Design AI Designed Antibodies Introduction
11.5.4 Institute for Protein Design Revenue in AI Designed Antibodies Business (2021–2026)
11.5.5 Institute for Protein Design Recent Development
11.6 Proteintech
11.6.1 Proteintech Company Details
11.6.2 Proteintech Business Overview
11.6.3 Proteintech AI Designed Antibodies Introduction
11.6.4 Proteintech Revenue in AI Designed Antibodies Business (2021–2026)
11.6.5 Proteintech Recent Development
11.7 AbCellera
11.7.1 AbCellera Company Details
11.7.2 AbCellera Business Overview
11.7.3 AbCellera AI Designed Antibodies Introduction
11.7.4 AbCellera Revenue in AI Designed Antibodies Business (2021–2026)
11.7.5 AbCellera Recent Development
11.8 LabGenius
11.8.1 LabGenius Company Details
11.8.2 LabGenius Business Overview
11.8.3 LabGenius AI Designed Antibodies Introduction
11.8.4 LabGenius Revenue in AI Designed Antibodies Business (2021–2026)
11.8.5 LabGenius Recent Development
11.9 Huashen
11.9.1 Huashen Company Details
11.9.2 Huashen Business Overview
11.9.3 Huashen AI Designed Antibodies Introduction
11.9.4 Huashen Revenue in AI Designed Antibodies Business (2021–2026)
11.9.5 Huashen Recent Development
11.10 Tencent
11.10.1 Tencent Company Details
11.10.2 Tencent Business Overview
11.10.3 Tencent AI Designed Antibodies Introduction
11.10.4 Tencent Revenue in AI Designed Antibodies Business (2021–2026)
11.10.5 Tencent Recent Development
11.11 Harbour BioMed
11.11.1 Harbour BioMed Company Details
11.11.2 Harbour BioMed Business Overview
11.11.3 Harbour BioMed AI Designed Antibodies Introduction
11.11.4 Harbour BioMed Revenue in AI Designed Antibodies Business (2021–2026)
11.11.5 Harbour BioMed Recent Development
11.12 Dynegene Technologies
11.12.1 Dynegene Technologies Company Details
11.12.2 Dynegene Technologies Business Overview
11.12.3 Dynegene Technologies AI Designed Antibodies Introduction
11.12.4 Dynegene Technologies Revenue in AI Designed Antibodies Business (2021–2026)
11.12.5 Dynegene Technologies Recent Development
11.13 XtalPi
11.13.1 XtalPi Company Details
11.13.2 XtalPi Business Overview
11.13.3 XtalPi AI Designed Antibodies Introduction
11.13.4 XtalPi Revenue in AI Designed Antibodies Business (2021–2026)
11.13.5 XtalPi Recent Development
11.14 BioGeom
11.14.1 BioGeom Company Details
11.14.2 BioGeom Business Overview
11.14.3 BioGeom AI Designed Antibodies Introduction
11.14.4 BioGeom Revenue in AI Designed Antibodies Business (2021–2026)
11.14.5 BioGeom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global AI Designed Antibodies Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Bispecific Antibodies
Table 3. Key Players of Multispecific Antibodies
Table 4. Global AI Designed Antibodies Market Size Growth Rate by Design Input (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Structure-driven
Table 6. Key Players of Sequence-driven
Table 7. Key Players of Hybrid-driven
Table 8. Global AI Designed Antibodies Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global AI Designed Antibodies Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 10. Global AI Designed Antibodies Market Size by Region (US$ Million), 2021–2026
Table 11. Global AI Designed Antibodies Market Share by Region (2021–2026)
Table 12. Global AI Designed Antibodies Forecasted Market Size by Region (US$ Million), 2027–2032
Table 13. Global AI Designed Antibodies Market Share by Region (2027–2032)
Table 14. AI Designed Antibodies Market Trends
Table 15. AI Designed Antibodies Market Drivers
Table 16. AI Designed Antibodies Market Challenges
Table 17. AI Designed Antibodies Market Restraints
Table 18. Global AI Designed Antibodies Revenue by Players (US$ Million), 2021–2026
Table 19. Global AI Designed Antibodies Market Share by Players (2021–2026)
Table 20. Global Top AI Designed Antibodies Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI Designed Antibodies Revenue, 2025
Table 21. Ranking of Global Top AI Designed Antibodies Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by AI Designed Antibodies Revenue (CR5 and HHI), 2021–2026
Table 23. Global Key Players of AI Designed Antibodies, Headquarters and Area Served
Table 24. Global Key Players of AI Designed Antibodies, Products and Applications
Table 25. Global Key Players of AI Designed Antibodies, Date of General Availability (GA)
Table 26. Mergers and Acquisitions, Expansion Plans
Table 27. Global AI Designed Antibodies Market Size by Type (US$ Million), 2021–2026
Table 28. Global AI Designed Antibodies Revenue Market Share by Type (2021–2026)
Table 29. Global AI Designed Antibodies Forecasted Market Size by Type (US$ Million), 2027–2032
Table 30. Global AI Designed Antibodies Revenue Market Share by Type (2027–2032)
Table 31. Global AI Designed Antibodies Market Size by Application (US$ Million), 2021–2026
Table 32. Global AI Designed Antibodies Revenue Market Share by Application (2021–2026)
Table 33. Global AI Designed Antibodies Forecasted Market Size by Application (US$ Million), 2027–2032
Table 34. Global AI Designed Antibodies Revenue Market Share by Application (2027–2032)
Table 35. North America AI Designed Antibodies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. North America AI Designed Antibodies Market Size by Country (US$ Million), 2021–2026
Table 37. North America AI Designed Antibodies Market Size by Country (US$ Million), 2027–2032
Table 38. Europe AI Designed Antibodies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 39. Europe AI Designed Antibodies Market Size by Country (US$ Million), 2021–2026
Table 40. Europe AI Designed Antibodies Market Size by Country (US$ Million), 2027–2032
Table 41. Asia-Pacific AI Designed Antibodies Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 42. Asia-Pacific AI Designed Antibodies Market Size by Region (US$ Million), 2021–2026
Table 43. Asia-Pacific AI Designed Antibodies Market Size by Region (US$ Million), 2027–2032
Table 44. Latin America AI Designed Antibodies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Latin America AI Designed Antibodies Market Size by Country (US$ Million), 2021–2026
Table 46. Latin America AI Designed Antibodies Market Size by Country (US$ Million), 2027–2032
Table 47. Middle East & Africa AI Designed Antibodies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Middle East & Africa AI Designed Antibodies Market Size by Country (US$ Million), 2021–2026
Table 49. Middle East & Africa AI Designed Antibodies Market Size by Country (US$ Million), 2027–2032
Table 50. Insilico Medicine Company Details
Table 51. Insilico Medicine Business Overview
Table 52. Insilico Medicine AI Designed Antibodies Product
Table 53. Insilico Medicine Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 54. Insilico Medicine Recent Development
Table 55. Generate:Biomedicines Company Details
Table 56. Generate:Biomedicines Business Overview
Table 57. Generate:Biomedicines AI Designed Antibodies Product
Table 58. Generate:Biomedicines Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 59. Generate:Biomedicines Recent Development
Table 60. Absci Company Details
Table 61. Absci Business Overview
Table 62. Absci AI Designed Antibodies Product
Table 63. Absci Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 64. Absci Recent Development
Table 65. Chai Discovery Company Details
Table 66. Chai Discovery Business Overview
Table 67. Chai Discovery AI Designed Antibodies Product
Table 68. Chai Discovery Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 69. Chai Discovery Recent Development
Table 70. Institute for Protein Design Company Details
Table 71. Institute for Protein Design Business Overview
Table 72. Institute for Protein Design AI Designed Antibodies Product
Table 73. Institute for Protein Design Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 74. Institute for Protein Design Recent Development
Table 75. Proteintech Company Details
Table 76. Proteintech Business Overview
Table 77. Proteintech AI Designed Antibodies Product
Table 78. Proteintech Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 79. Proteintech Recent Development
Table 80. AbCellera Company Details
Table 81. AbCellera Business Overview
Table 82. AbCellera AI Designed Antibodies Product
Table 83. AbCellera Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 84. AbCellera Recent Development
Table 85. LabGenius Company Details
Table 86. LabGenius Business Overview
Table 87. LabGenius AI Designed Antibodies Product
Table 88. LabGenius Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 89. LabGenius Recent Development
Table 90. Huashen Company Details
Table 91. Huashen Business Overview
Table 92. Huashen AI Designed Antibodies Product
Table 93. Huashen Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 94. Huashen Recent Development
Table 95. Tencent Company Details
Table 96. Tencent Business Overview
Table 97. Tencent AI Designed Antibodies Product
Table 98. Tencent Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 99. Tencent Recent Development
Table 100. Harbour BioMed Company Details
Table 101. Harbour BioMed Business Overview
Table 102. Harbour BioMed AI Designed Antibodies Product
Table 103. Harbour BioMed Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 104. Harbour BioMed Recent Development
Table 105. Dynegene Technologies Company Details
Table 106. Dynegene Technologies Business Overview
Table 107. Dynegene Technologies AI Designed Antibodies Product
Table 108. Dynegene Technologies Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 109. Dynegene Technologies Recent Development
Table 110. XtalPi Company Details
Table 111. XtalPi Business Overview
Table 112. XtalPi AI Designed Antibodies Product
Table 113. XtalPi Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 114. XtalPi Recent Development
Table 115. BioGeom Company Details
Table 116. BioGeom Business Overview
Table 117. BioGeom AI Designed Antibodies Product
Table 118. BioGeom Revenue in AI Designed Antibodies Business (US$ Million), 2021–2026
Table 119. BioGeom Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Authors List of This Report
List of Figures
Figure 1. AI Designed Antibodies Picture
Figure 2. Global AI Designed Antibodies Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global AI Designed Antibodies Market Share by Type: 2025 vs 2032
Figure 4. Bispecific Antibodies Features
Figure 5. Multispecific Antibodies Features
Figure 6. Global AI Designed Antibodies Market Size Comparison by Design Input (US$ Million), 2021–2032
Figure 7. Structure-driven Features
Figure 8. Sequence-driven Features
Figure 9. Hybrid-driven Features
Figure 10. Global AI Designed Antibodies Market Size by Application (US$ Million), 2021–2032
Figure 11. Global AI Designed Antibodies Market Share by Application: 2025 vs 2032
Figure 12. Biological Experiments Case Studies
Figure 13. Drug Development Case Studies
Figure 14. Others Case Studies
Figure 15. AI Designed Antibodies Report Years Considered
Figure 16. Global AI Designed Antibodies Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 17. Global AI Designed Antibodies Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global AI Designed Antibodies Market Share by Region: 2025 vs 2032
Figure 19. Global AI Designed Antibodies Market Share by Players in 2025
Figure 20. Global AI Designed Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by AI Designed Antibodies Revenue in 2025
Figure 22. North America AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. North America AI Designed Antibodies Market Share by Country (2021–2032)
Figure 24. United States AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Canada AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe AI Designed Antibodies Market Share by Country (2021–2032)
Figure 28. Germany AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. France AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. U.K. AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Italy AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Russia AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Ireland AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific AI Designed Antibodies Market Share by Region (2021–2032)
Figure 36. China AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Japan AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. South Korea AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Southeast Asia AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. India AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Australia & New Zealand AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America AI Designed Antibodies Market Share by Country (2021–2032)
Figure 44. Mexico AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Brazil AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa AI Designed Antibodies Market Share by Country (2021–2032)
Figure 48. Israel AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Saudi Arabia AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. UAE AI Designed Antibodies Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Insilico Medicine Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 52. Generate:Biomedicines Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 53. Absci Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 54. Chai Discovery Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 55. Institute for Protein Design Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 56. Proteintech Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 57. AbCellera Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 58. LabGenius Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 59. Huashen Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 60. Tencent Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 61. Harbour BioMed Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 62. Dynegene Technologies Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 63. XtalPi Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 64. BioGeom Revenue Growth Rate in AI Designed Antibodies Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
